Constantine Cannon LLP - Whistleblower Practice

08/12/2026

🔬Healthcare fraud enforcement continues. Orchard Laboratories Corporation has agreed to pay $6.49M to resolve allegations it violated the False Claims Act by billing Medicare for OTC COVID-19 tests that were allegedly never requested or delivered to beneficiaries.

This case highlights the government’s continued focus on fighting healthcare fraud and holding providers accountable for improper Medicare billing.
Learn more in our blog post: https://constantinecannon.com/whistleblower/orchard-laboratories-corporation-agrees-to-settle-false-claims-act-allegations-for-6494290-00/

08/11/2026

💰A recent $16.2 million Medicaid fraud settlement serves as a reminder that combating healthcare billing fraud remains a top enforcement priority for the government.

Addiction Recovery Care, LLC (ARC) and two affiliates have agreed to settle a civil judgment to resolve allegations they defrauded the Kentucky Medicaid program.

According to the government, the alleged misconduct included upcoding behavioral health services by misrepresenting clinical qualifications; billing at higher individual-therapy rates for services allegedly provided as group therapy; submitting duplicate office visit claims and billing for services already covered under Medicaid’s per diem payments; and billing for care management services that allegedly did not meet Medicaid requirements.

The case began with a (or qui tam) lawsuit filed by current and former employees.

https://constantinecannon.com/whistleblower/addiction-recovery-care-and-affiliates-pay-16-2m-civil-judgment-to-resolve-kentucky-medicaid-fraud-allegations/

08/09/2026

🔬Another major DOJ healthcare kickbacks settlement: Last week, Access DX Laboratory, its former CEO, and a Florida businessman agreed to pay $36.4M to resolve allegations they violated the False Claims Act and Anti-Kickback Statute by paying for patient referrals, securing sham doctors’ orders, and billing Medicare and Medicaid for medically unnecessary genetic testing.

The case follows a steady stream of similar enforcement actions that continue to serve as reminders that healthcare decisions must be driven by the bests interests of the patient without being influenced by improper financial incentives.

🗣️This case was initiated by a , an insider who will receive a $7.2M whistleblower award for helping expose the alleged misconduct.

https://constantinecannon.com/whistleblower/another-whistleblower-originated-false-claims-act-kickback-settlement/

08/06/2026

🔬NeoGenomics agreed to pay $9.8 million to settle allegations that it violated the False Claims Act by providing illegal kickbacks.

To generate referrals, NeoGenomics allegedly provided services to healthcare providers for less than fair market value. These kickbacks violated the Anti-Kickback Statute, while NeoGenomics’ financial relationship with the providers and the submission of claims for its services violated the Stark Law.

Learn more about this enforcement action here: https://constantinecannon.com/whistleblower/neogenomics-pays-9-8m-to-resolve-potential-false-claims-act-violations-related-to-alleged-lab-testing-kickbacks/

08/05/2026

🎉Last week, the publicly celebrated whistleblowers and made its message loud and clear: It wants to hear from whistleblowers!

In honor of National Whistleblower Day, the agency recognized the essential role whistleblowers play in exposing tax fraud, narrowing the tax gap, and strengthening compliance.

This is just the latest effort by the IRS to advance its Whistleblower Program. This includes increased outreach to potential whistleblowers, a multi-year plan to improve the efficiency and transparency of the program, and a renewed focus on providing whistleblower awards more quickly.

So, if you have any information about potential tax fraud, the IRS is ready and waiting with open arms, and a potentially sizeable award for your efforts.


https://constantinecannon.com/whistleblower/irs-honors-whistleblowers-with-national-whistleblower-day-shout-out/

08/04/2026

🚢 The DOJ announced that it had surpassed the $1B threshold in customs fraud recoveries since launching its Trade Fraud Task Force last year. In conjunction with the announcement, DOJ released a Resource Guide to Trade Fraud Enforcement to direct whistleblowers to the most common areas of customs fraud.

In our recent blog post, we discussed this news and examined how whistleblowers continue to carry this fight against fraud.

Constantine Cannon whistleblower attorney Dan Noel applauded the Government’s efforts and weighed in on the critical role of whistleblowers in the Government’s enforcement crusade: “The Government recognizes the critical role whistleblowers play in reporting customs fraud,” Noel says, “and has made it very clear it wants and needs their help in this area.” He adds, “The newly released Resource Guide is just the Government’s latest effort to invite whistleblowers into the fold and direct them to where customs activity is most ripe for foul play.”

https://constantinecannon.com/whistleblower/doj-continues-full-court-press-against-customs-fraud-and-for-whistleblowers-to-help-the-charge/

08/01/2026

🏥🩺⚕️Over the past few weeks, the government has announced a slew of COVID-19-related fraud enforcement actions. In our blog post, we’re diving into the recent news and what this could indicate in terms of the government’s future enforcement priorities.

Several of the cases we’re reporting on were initiated by whistleblowers. The alleged schemes involved , fraudulently obtaining emergency funding from Paycheck Protection Program (PPP) loans, fraudulent billings, and more.

Learn more about these cases here: https://constantinecannon.com/whistleblower/catching-a-covid-19-era-fugitive-and-more-covid-19-related-fraud-enforcement-actions/

The government recently announced a slew of COVID-19-related fraud enforcement actions. Several of the cases were initiated by whistleblowers

07/30/2026

🥼The continues its fight against fraud. On July 15, the U.S. Attorney’s Office for the District of Massachusetts announced that Labcorp agreed to pay $14.5M to resolve allegations that it violated the by submitting medically unnecessary claims for urine drug testing to Medicare.

Labcorp agreed to pay $14.5M to resolve allegations that it violated the False Claims Act by submitting medically unnecessary claims for urine drug testing to Medicare.